Landmark Clinical Study Published for Outpatient Bladder Cancer Treatment, Initiating European Patient Treatments

Multi4 Medical has announced the publication of a landmark clinical study in BJU International, confirming that its Multi4 instrument enables outpatient management of recurrent Non-Muscle Invasive Bladder Cancer (NMIBC). The study details the world's first all-in-one instrument for outpatient bladder cancer management, performing both therapeutic treatment and diagnostic tissue sampling in a single procedure, eliminating the need for general anesthesia or hospitalization. Following CE-mark approval, the company has initiated its first patient treatments in Sweden.